|Bid||0.34 x 2200|
|Ask||0.85 x 10000|
|Day's Range||0.55 - 0.59|
|52 Week Range||0.51 - 2.48|
|PE Ratio (TTM)||-0.80|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||5.50|
THE WOODLANDS, Texas, May 18, 2017-- Repros Therapeutics Inc, announced today that it has entered into an underwriting agreement to sell in a public offering 2,744,125 shares of the Company’ s common stock ...
THE WOODLANDS, Texas, May 17, 2017-- Repros Therapeutics Inc. today announced that it intends to offer primary shares of its common stock and warrants to purchase shares of its common stock in an underwritten ...
On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 22 cents. The biopharmaceutical company posted revenue of $7,000 in the period. In the final minutes of trading on Tuesday, ...